Functional disruption of the PD-1 locus by sgRNA:Cas9 led to upregulation of IFN-γ and enhanced primary human T cell cytotoxicity on tumor cell lines (61) and in patients with refractory NSCLC (62). The gene discussed is PDCD1; the disease is neoplasm.